Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.
about
Corticosteroids for the treatment of Duchenne muscular dystrophyAssisted standing for Duchenne muscular dystrophyInterventions to prevent steroid-induced osteoporosis and osteoporotic fractures in Duchenne muscular dystrophyVoltage-gated ion channel dysfunction precedes cardiomyopathy development in the dystrophic heartRecent advances in innovative therapeutic approaches for Duchenne muscular dystrophy: from discovery to clinical trialsCurrent and emerging treatment strategies for Duchenne muscular dystrophyThe importance of genetic diagnosis for Duchenne muscular dystrophyCongenital and childhood myotonic dystrophy: Current aspects of disease and future directionsAssessment and management of respiratory function in patients with Duchenne muscular dystrophy: current and emerging optionsCardiac involvement in Duchenne and Becker muscular dystrophyProteomic profiling of the dystrophin-deficient mdx phenocopy of dystrophinopathy-associated cardiomyopathySplicing therapy for neuromuscular diseaseExtending the translational potential of targeting NO/cGMP-regulated pathways in the CVSBone health and associated metabolic complications in neuromuscular diseasesGalectin-1 Protein Therapy Prevents Pathology and Improves Muscle Function in the mdx Mouse Model of Duchenne Muscular DystrophyQuality improvement in neurology: muscular dystrophy quality measuresDuchenne muscular dystrophy: the management of scoliosisNutraceuticals and Their Potential to Treat Duchenne Muscular Dystrophy: Separating the Credible from the ConjectureA protocol to develop clinical guidelines for inclusion-body myositisThe TREAT-NMD advisory committee for therapeutics (TACT): an innovative de-risking model to foster orphan drug developmentTreatment with a nitric oxide-donating NSAID alleviates functional muscle ischemia in the mouse model of Duchenne muscular dystrophyPregnancy-induced amelioration of muscular dystrophy phenotype in mdx mice via muscle membrane stabilization effect of glucocorticoidMurine and human myogenic cells identified by elevated aldehyde dehydrogenase activity: implications for muscle regeneration and repairCan outcomes in Duchenne muscular dystrophy be improved by public reporting of data?The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study.Chemical shift-based MRI to measure fat fractions in dystrophic skeletal muscle.Aquatic therapy for boys with Duchenne muscular dystrophy (DMD): an external pilot randomised controlled trial.Functional Neuronal Differentiation of Injury-Induced Muscle-Derived Stem Cell-Like Cells with Therapeutic Implications.Upper Limb Evaluation in Duchenne Muscular Dystrophy: Fat-Water Quantification by MRI, Muscle Force and Function Define Endpoints for Clinical TrialsAnalysis of Pulmonary Function Test in Korean Patients With Duchenne Muscular Dystrophy: Comparison of Foreign and Korean Reference Data.Targeting TGF-β Signaling by Antisense Oligonucleotide-mediated Knockdown of TGF-β Type I Receptor.Decreased inward rectifier potassium current IK1 in dystrophin-deficient ventricular cardiomyocytes.Engaging Patients and Caregivers Managing Rare Diseases to Improve the Methods of Clinical Guideline Development: A Research Protocol.Limb-girdle and congenital muscular dystrophies: current diagnostics, management, and emerging technologies.Cooperative International Neuromuscular Research Group Duchenne Natural History Study demonstrates insufficient diagnosis and treatment of cardiomyopathy in Duchenne muscular dystrophyEvaluation of muscular changes by ultrasound Nakagami imaging in Duchenne muscular dystrophy.Selective modulation through the glucocorticoid receptor ameliorates muscle pathology in mdx micePDE5 inhibition alleviates functional muscle ischemia in boys with Duchenne muscular dystrophy.Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy.The burden of Duchenne muscular dystrophy: an international, cross-sectional study.
P2860
Q24185788-C5641000-FA4A-4482-BC1D-A148995584E8Q24187775-C64BCCE8-CF34-44D8-9257-8E281F73DA49Q24198280-3D784DB7-2185-4449-8EFF-3C940D02452AQ24306601-87F61C45-6A97-4F86-B317-CB72C478BBF5Q26741409-4285EFC9-FEBC-4A4E-BBAA-D5CADE30F26BQ26741535-EFD30DE3-B561-407F-98B8-D679B93A3197Q26769701-88C99C75-060F-494F-A207-5EE1F67C1590Q26777206-94125D87-435A-425F-8AE5-FB96A36F1F58Q26785627-B270AD66-DAE7-4B49-9321-DD8AD9ADBA37Q26801616-5A5E1C8B-784C-45EE-BC4A-1FB94A1FB759Q27006945-EFEABEA1-0F31-4E87-90D6-6AA92D5FBD4CQ27009581-2C08A700-F530-483E-B60C-4B74F0E8DD2CQ27021649-BF474950-6D68-4940-87FD-2D6FDD89C9F1Q27025688-C1D38D91-AECF-430E-98C0-1DF4C7BEEB8BQ27318308-CFA3D451-4977-4CDB-AFF7-121798AB09BEQ27348818-F86D9349-791B-4172-9AF1-8569A64E2C09Q28067793-13479270-BD8F-4F23-B149-5A59B60B0E87Q28072269-39FC04EA-B211-4E4C-AB91-C1AFA0CB87A6Q28077552-370EE9E7-9FCB-4DAE-9AFE-051A4C6E5223Q28088277-90254CF2-7FCA-4643-A0B8-9786919B687AQ28484851-4FADDBFF-0B9C-4398-B06E-5857BDF836FDQ28544401-76410770-4B34-4992-AAE0-A38B14DD64A4Q28741359-B8A1B25D-F26E-4EF8-80D9-43FC7099F197Q30000808-16DE9294-5DA1-48AD-A8C3-2AEF11E2DBECQ30557216-8782CD39-055D-421F-9113-413E00EE4FD8Q30665063-6D4E557E-FD50-4092-8137-6087DF081A43Q30842938-C8749256-BD4E-4853-8009-B4787C352345Q30850601-5E8F4AD1-BDFE-407F-B108-EC222ADF178FQ31131975-B1790AD4-54FC-44E5-844D-FA491C2D6B69Q31142494-CA455D25-6793-4D67-BC95-9435BAF811ECQ33570741-BE9CD6E5-60AA-437D-836E-82A3123BF343Q33584881-055B50C7-6C8D-49F1-9527-352236B6DD5DQ33676797-3B80F868-08D9-4EA4-86AC-5FCF517EE27DQ33837536-050B51AA-CEF2-48BB-AF37-C1DD323EE33CQ33844719-F2E1635E-E42D-4996-A7E6-6E4E30C47965Q33860859-ED1E6236-5A8B-4F9E-A3E2-1151BBBB46D1Q33925571-FE939E34-DD73-4529-A058-4F2AEEF1BBEBQ33987140-3D26B9E4-DDAC-4662-82AA-5FA50085B0A1Q33991780-80B5459B-AAE6-40F8-A823-1EFF3BA6AE96Q34079312-FD8B855A-4ED6-46CB-8007-35D308E5DAC2
P2860
Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Diagnosis and management of Du ...... ion of multidisciplinary care.
@en
Diagnosis and management of Du ...... ion of multidisciplinary care.
@nl
type
label
Diagnosis and management of Du ...... ion of multidisciplinary care.
@en
Diagnosis and management of Du ...... ion of multidisciplinary care.
@nl
prefLabel
Diagnosis and management of Du ...... ion of multidisciplinary care.
@en
Diagnosis and management of Du ...... ion of multidisciplinary care.
@nl
P2093
P50
P1433
P1476
Diagnosis and management of Du ...... ion of multidisciplinary care.
@en
P2093
Carolyn Constantin
DMD Care Considerations Working Group
Frederic Shapiro
James Poysky
Jean Tomezsko
Katharine Bushby
Kathi Kinnett
Linda Cripe
Paula R Clemens
P304
P356
10.1016/S1474-4422(09)70272-8
P577
2009-11-27T00:00:00Z